rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
2
|
pubmed:dateCreated |
2010-8-2
|
pubmed:databankReference |
|
pubmed:abstractText |
Guidelines for the treatment of patients with allergic rhinitis (AR) recommend intranasal corticosteroids as first-line therapy. In clinical trials, however, only 50% of patients obtain excellent symptom control.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
1081-1206
|
pubmed:author |
|
pubmed:copyrightInfo |
Copyright 2010 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.
|
pubmed:issnType |
Print
|
pubmed:volume |
105
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
155-61
|
pubmed:meshHeading |
pubmed-meshheading:20674827-Acetates,
pubmed-meshheading:20674827-Adolescent,
pubmed-meshheading:20674827-Adult,
pubmed-meshheading:20674827-Androstadienes,
pubmed-meshheading:20674827-Anti-Inflammatory Agents,
pubmed-meshheading:20674827-Chemotherapy, Adjuvant,
pubmed-meshheading:20674827-Feasibility Studies,
pubmed-meshheading:20674827-Female,
pubmed-meshheading:20674827-Humans,
pubmed-meshheading:20674827-Leukotriene Antagonists,
pubmed-meshheading:20674827-Male,
pubmed-meshheading:20674827-Middle Aged,
pubmed-meshheading:20674827-Quality of Life,
pubmed-meshheading:20674827-Questionnaires,
pubmed-meshheading:20674827-Quinolines,
pubmed-meshheading:20674827-Rhinitis, Allergic, Perennial,
pubmed-meshheading:20674827-Skin Tests,
pubmed-meshheading:20674827-Treatment Outcome
|
pubmed:year |
2010
|
pubmed:articleTitle |
Effect of the addition of montelukast to fluticasone propionate for the treatment of perennial allergic rhinitis.
|
pubmed:affiliation |
Section of Otolaryngology-Head and Neck Surgery, The University of Chicago Medical Center and Pritzker School of Medicine, The University of Chicago, Chicago, Illinois 60637, USA.
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|